Countries China
Sanyou ,KangaBio to accelerate antibody drug development and innovation
KangaBio, as a rising star biotechnology company, is committed to developing innovative prodrugs and providing innovative medicine to address unmet clinica...
August 29, 2022 | News
Everest Medicines Announces the Departure of CEO, Kerry Blanchard
Dr. Kerry Blanchard has resigned as Chief Executive Officer and as a member of the Board of Directors, effective immediately. He will remain as a...
August 26, 2022 | News
Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies
Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...
August 25, 2022 | News
Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China
Ensifentrine is a first-in-class, dual inhibitor of the enzymes phosphodiesterase 3 and 4 ("PDE3" and "PDE4") combining bronchodilator and anti-inflam...
August 21, 2022 | News
Henlius 2022 H1 Results: Sharpen all-round edges, advance in evolution to Biopharma
In the first half of 2022, Henlius revenue reached approximately RMB1.289 billion, representing an increase of 103.5% YoY, which mainly benefited from...
August 19, 2022 | News
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine
The phase III clinical trial of REC603 in China consists of three parts, i.e. the efficacy trial, the immuno-bridging trial in younger-age groups...
August 11, 2022 | News
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development
Biomedical industry is an important part of Wuxi's modern industrial system construction during the 14th Five-Year Plan(2021-2025) period. Its scale topped...
August 09, 2022 | News
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
Collaboration to accelerate the development and access of oncology medicines for cancer patients in China Clinical trial programs combining two of ...
August 05, 2022 | News
Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China
LNK01004 is a novel kinase inhibitor that can simultaneously inhibit multiple cytokine-induced signaling pathways in vitro and in vivo. LNK01004 is tissue-...
August 04, 2022 | News
ZAODX World Conference on Early Detection of Cancer was successfully held in Guangzhou, China
In attendance were founders and representatives from over 100 leading companies and institutions involved in cancer screening and early detection from nume...
August 01, 2022 | News
Lynk Pharmaceuticals Announces First Participants in Phase I Trial of LNK01004
This study is to evaluate the safety, tolerability, and pharmacokinetics of the LNK01004 ointment in healthy adults and patients with mild to moderate plaq...
July 29, 2022 | News
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy
Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously d...
July 27, 2022 | News
Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...
July 20, 2022 | News
WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
WuXi STA, a subsidiary of WuXi AppTec, announced that it has opened a new continuous manufacturing (flow chemistry) plant at its Changzhou campus in ...
July 20, 2022 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
